Adaptive Biotechnologies (NASDAQ:ADPT) has priced its IPO of 15M common shares at $20/share for gross proceeds of $300M.
Underwriters over-allotment is an additional 2.25M common shares.
Shares will begin trading on Nasdaq on June 27 under the ticker symbol “ADPT.”
Closing date is July 1.
Source: Press Release
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.